Health In Tech vs Zhibao Technology
HIT and ZBAO side by side, both in insurance agents, brokers, and service. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HIT and ZBAO compare
Zhibao Technology grew revenue faster over the last twelve months (50.8% versus 23.0% for Health In Tech).
Health In Tech keeps more of each dollar of sales as profit, with a net margin of −12.0% compared with −22.4% at Zhibao Technology.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HIT | ZBAO |
|---|---|---|
| Size and price | ||
| Market cap | $36.7M | – |
| Share price | $0.559 | $0.219 |
| Change, 1 year | −80.8% | −99.5% |
| Beta (5Y) | 1.45 | 1.53 |
| Employees | 87 | 65 |
| StockData Score | ||
| Total score | 3 | 3 |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 | 3 (better) |
| Performance score | 0 | 0 |
| Health score | 1 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.1× | – |
| Growth | ||
| Revenue growth (TTM) | 23.0% | 50.8% (better) |
| Net income growth (TTM) | −390% (better) | −568% |
| EPS growth (TTM) | −333% (better) | −541% |
| Profitability | ||
| Gross margin | 53.9% (better) | 41.0% |
| Operating margin | – | −19.3% |
| Net margin | −12.0% (better) | −22.4% |
| Return on equity | −24.0% (better) | −134% |
| Financial health | ||
| Debt / equity | – | 1.79 |
| Current ratio | 2.18 (better) | 0.86 |
| Altman Z-score | 3.84 | – |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 7.1% | 0.01% |
| Held by insiders | 76.6% | 72.3% |
| Insider net buying, 12 months | −$40.6K | – |
| Short interest, % of float | 3.9% | – |
Go deeper
- HIT stock overview
- HIT income statement
- HIT valuation and score
- ZBAO stock overview
- ZBAO income statement
- ZBAO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.